Skip to Content

Erwinaze

In the US, Erwinaze (asparaginase erwinia chrysanthemi systemic) is a member of the drug class miscellaneous antineoplastics and is used to treat Acute Lymphoblastic Leukemia and Acute Lymphocytic Leukemia.

US matches:

Ingredient matches for Erwinaze

Asparaginase

Asparaginase Erwinia chrysanthemi (a derivative of Asparaginase) is reported as an ingredient of Erwinaze in the following countries:

  • United States

International Drug Name Search

Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Hide